Autoimmune and Inflammatory Diseases

Metabolon’s non-biased global metabolomic screening platform is a powerful tool for identifying biomarkers related to disease and drug therapy.  Collaborative studies in Inflammatory Bowel Disease (Crohn’s and Ulcerative Colitis), rheumatoid and osteoarthritis are currently underway or in the planning stages.

While pursuing our development pipeline, Metabolon scientists continue to evaluate other disease areas for diagnostic development.  Please contact us if you are interested in evaluating a collaborative relationship with Metabolon’s diagnostic team.

Additional
Resources

Applications of Metabolomics in Drug Discovery and Development

Metabolomics for Biomarker Discovery